Viewing StudyNCT00278213



Ignite Creation Date: 2024-05-05 @ 4:36 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00278213
Status: COMPLETED
Last Update Posted: 2018-05-11
First Post: 2006-01-16

Brief Title: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Sponsor: German CLL Study Group
Organization: German CLL Study Group

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-09
Start Date Type: None
Primary Completion Date: 2007-02
Primary Completion Date Type: ACTUAL
Completion Date: 2009-12
Completion Date Type: ACTUAL
First Submit Date: 2006-01-16
First Submit QC Date: January 16 2006
Study First Post Date: 2006-01-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-05-09
Last Update Post Date: 2018-05-11
Last Update Post Date Type: ACTUAL